New surgery technique for first-time bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing a new way to perform surgery for people with newly diagnosed non-muscle-invasive bladder cancer. The goal is to see if a special technique during the tumor removal procedure can help reduce the chance of the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to sign a consent form agreeing to take part in the study.
- You are scheduled to have a TURB procedure to remove a bladder tumor that is larger than 1.5 cm (about half an inch).
- This should be your first time being diagnosed with bladder cancer.
- You cannot have had bladder cancer before that came back after treatment.
- You cannot have cancer that has spread outside your bladder or is suspected to be invasive muscle cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special device that may help doctors remove bladder tumors in one piece during surgery. The device is used along with the standard surgery to see if it removes the whole tumor more easily and safely.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This trial tests whether using a patient's own tumor cells in lab-made clusters (PTCs) can help guide chemotherapy before bladder removal surgery for muscle-invasive bladder cancer. If you qualify, you'll receive personalized treatment followed by surgery.
This clinical trial tests a new drug, BH011, for people with high-risk, non-muscle-invasive bladder cancer that has come back or not responded to BCG therapy. The goal is to see if the drug is safe and works well when given directly into the bladder, as an alternative to bladder removal surgery.
This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.
This trial tests a combination of two treatments after bladder tumor surgery: a drug called toripalimab (given through a vein) plus BCG therapy (given into the bladder) for people with high-risk non-muscle-invasive bladder cancer. The goal is to see if this combination can help prevent the cancer from coming back.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.